var data={"title":"Normal adrenarche","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Normal adrenarche</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/normal-adrenarche/contributors\" class=\"contributor contributor_credentials\">Robert L Rosenfield, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/normal-adrenarche/contributors\" class=\"contributor contributor_credentials\">Mitchell E Geffner, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/normal-adrenarche/contributors\" class=\"contributor contributor_credentials\">Alison G Hoppin, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/normal-adrenarche/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jun 05, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Adrenarche is the term for the maturational increase in adrenal androgen production that normally becomes biochemically apparent at about six years of age in both girls and boys (<a href=\"image.htm?imageKey=PEDS%2F79533\" class=\"graphic graphic_figure graphicRef79533 \">figure 1</a>) [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/1,2\" class=\"abstract_t\">1,2</a>]. It is characterized by production of increasing amounts of weak androgens by the adrenal cortex, which contribute to the development of pubic hair. Although the clinical manifestations of adrenarche ordinarily closely follow true puberty, the two phenomena may be dissociated, as occurs in the presence of hypogonadism [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/3,4\" class=\"abstract_t\">3,4</a>]. Thus, adrenarche seems to be unrelated to the pubertal maturation of the hypothalamic-pituitary-gonadal axis. Adrenarche is a unique phenomenon confined with rare exceptions to a few higher primates [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/5-8\" class=\"abstract_t\">5-8</a>]. (See <a href=\"#H4\" class=\"local\">'Clinical manifestations of adrenarche'</a> below.) </p><p>Premature adrenarche is an incomplete, benign, slowly progressive form of premature puberty that is usually a common extreme variant of normal development. However, it may be a risk factor for a future hyperandrogenic disorder. The term is used to designate a very mild form of androgen excess, most often manifest as premature pubarche (the isolated appearance of sexual hair before the age of eight years in girls and nine years in boys). The evaluation of a child with premature adrenarche is discussed in a separate topic review. (See <a href=\"topic.htm?path=premature-adrenarche\" class=\"medical medical_review\">&quot;Premature adrenarche&quot;</a>.) </p><p class=\"headingAnchor\" id=\"H24070873\"><span class=\"h1\">PHYSIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Adrenarche is the result of a developmental change in the pattern of adrenal secretory response to adrenocorticotropic hormone (ACTH) [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/9\" class=\"abstract_t\">9</a>]. During adrenarche, the pattern of adrenal steroid levels changes in a unique way (<a href=\"image.htm?imageKey=PEDS%2F75217\" class=\"graphic graphic_table graphicRef75217 \">table 1</a>). In the preadrenarchal child, ACTH stimulates cortisol secretion, but has very little effect on 17-ketosteroid secretion. During adrenarche, 17-ketosteroid responsiveness to ACTH gradually increases in a selective manner, while cortisol responsiveness to ACTH remains unchanged (<a href=\"image.htm?imageKey=PEDS%2F53342\" class=\"graphic graphic_figure graphicRef53342 \">figure 2</a>). The adrenarchal secretory pattern is characterized by disproportionate responsiveness of <span class=\"nowrap\">&Delta;<sup>5</sup>-steroid</span> intermediates (17-hydroxypregnenolone and dehydroepiandrosterone, DHEA) relative to <span class=\"nowrap\">&Delta;<sup>4</sup>-steroid</span> intermediates (eg, 17-hydroxyprogesterone and androstenedione) in the presence of stable responses of cortisol (<a href=\"image.htm?imageKey=PEDS%2F58179\" class=\"graphic graphic_figure graphicRef58179 \">figure 3</a>) [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/9\" class=\"abstract_t\">9</a>]. As a result, dehydroepiandrosterone sulfate (DHEAS) becomes the predominant 17-ketosteroid in blood and main marker of adrenarche. &#160;</p><p>These adrenarchal changes are ACTH-dependent [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/9,10\" class=\"abstract_t\">9,10</a>], ie, they are not manifest in the absence of ACTH. They are caused by changes in response to ACTH rather than a change in ACTH secretion. This pattern of androgen production differs from that caused by excessive ACTH stimulation in the preadrenarchal child, in whom androstenedione becomes relatively prominent [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/11\" class=\"abstract_t\">11</a>]. After adrenarche, adrenal androgens are more sensitive than cortisol to suppression by glucocorticoid administration, providing further evidence that these hormones are differentially ACTH-responsive [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/12,13\" class=\"abstract_t\">12,13</a>]. </p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h2\">Anatomic site and mechanism of biochemical changes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The zona reticularis of the adrenal cortex is a major source of the adrenarchal steroids (<a href=\"image.htm?imageKey=PEDS%2F58179\" class=\"graphic graphic_figure graphicRef58179 \">figure 3</a>) [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/3,5,14,15\" class=\"abstract_t\">3,5,14,15</a>]. The increased synthesis of 17-hydroxypregnenolone, DHEA, and DHEAS during adrenarche occurs as a byproduct of ACTH stimulation of cortisol synthesis [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/9,10\" class=\"abstract_t\">9,10</a>]. ACTH effects on adrenal androgen production are modulated by diverse signaling networks [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/16\" class=\"abstract_t\">16</a>]. Modulators of the androgenic response to ACTH include a stimulatory isoform of DENND1A <span class=\"nowrap\">(DENN/MADD</span> domain-containing protein 1A; DENND1A.V2) that is known to be over-expressed in polycystic ovary syndrome theca cells, and BMP4 (bone morphogenetic protein type 4), which is inhibitory. Leptin, an adipocyte hormone, stimulates the 17,20-lyase activity of adrenocortical cells [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/17\" class=\"abstract_t\">17</a>], which shunts adrenal steroidogenesis away from cortisol and toward DHEAS production. Interleukin-6, which stimulates ACTH secretion, is also strongly expressed in the zona reticularis of the adrenal cortex where it directly stimulates production of all classes of adrenal steroids independently of ACTH [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/18,19\" class=\"abstract_t\">18,19</a>].</p><p>Adrenocortical stem and progenitor cells appear to be located in the capsular and subcapsular (outer zona glomerulosa) region of the adrenal cortex and daughter cells then proliferate toward the corticomedullary junction to establish the zones of the definitive adrenal cortex [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/20,21\" class=\"abstract_t\">20,21</a>]. Zona reticularis cells appear to arise from this population in an age-dependent manner [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/22\" class=\"abstract_t\">22</a>], rather than from persistent cells of the fetal zone that have failed to undergo involution, as was originally postulated [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/23\" class=\"abstract_t\">23</a>]. In rhesus monkeys, the fetal zone develops from a cell type that is distinct from that of the reticularis zone [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/6,7\" class=\"abstract_t\">6,7</a>]. </p><p>The zona reticularis begins to form in the central adrenal cortex at three to four years of age. At about five years of age, it begins to develop into a continuous zone. Within about a year, the adrenarchal increase in DHEAS production becomes detectible.</p><p>The adrenarchal pattern of adrenal secretion results from a unique enzyme expression profile in the zona reticularis. These cells express low levels of the gene encoding 3&szlig;-hydroxysteroid dehydrogenase type 2 (HSD3B2) but high levels of the genes encoding cytochrome b5 (CYB5), steroid sulfotransferase 2A1 (SULT2A1), and 17&szlig;-hydroxysteroid dehydrogenase type 5 (HSD17B5) (<a href=\"image.htm?imageKey=PEDS%2F58179\" class=\"graphic graphic_figure graphicRef58179 \">figure 3</a>) [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/5,15,24\" class=\"abstract_t\">5,15,24</a>]. </p><p>Low activity of the HSD3B2 enzyme (3&szlig;-HSD2) underlies these cells' poor production of cortisol and other <span class=\"nowrap\">&Delta;<sup>4</sup></span> steroids in favor of formation of <span class=\"nowrap\">&Delta;<sup>5</sup>-steroids</span> [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/14,25\" class=\"abstract_t\">14,25</a>]. This enzyme activity is low not only because of low gene expression, but because enzyme activity is inhibited by substrate end-products in a dose-related manner, particularly cortisol [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/26\" class=\"abstract_t\">26</a>], androstenedione [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/27,28\" class=\"abstract_t\">27,28</a>], and estradiol [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/29\" class=\"abstract_t\">29</a>]. High fatty acid levels also seem to inhibit activity of this enzyme [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/30\" class=\"abstract_t\">30</a>].</p><p>Activity of CYP17 is also increased in the zona reticularis. This cytochrome P450 enzyme has two actions: 17&alpha;-hydroxylase activity and 17,20-lyase activity, which preferentially and respectively catalyze the conversion of pregnenolone to 17-hydroxypregnenolone (which is an essential precursor of both cortisol and sex steroids) and then 17-hydroxypregnenolone to DHEA (<a href=\"image.htm?imageKey=PEDS%2F58179\" class=\"graphic graphic_figure graphicRef58179 \">figure 3</a>) [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/15,31\" class=\"abstract_t\">15,31</a>]. Preferential expression of CYB5 in the zona reticularis enhances the lyase activity of CYP17 [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/32\" class=\"abstract_t\">32</a>]. (See <a href=\"topic.htm?path=adrenal-steroid-biosynthesis\" class=\"medical medical_review\">&quot;Adrenal steroid biosynthesis&quot;</a>.)</p><p>All of the above factors favor the formation of DHEA from 17-hydroxypregnenolone by the zona reticularis. The coincident preferential expression of SULT2A1 in this zone then converts DHEA to the relatively inert DHEAS, which acts as a &quot;sump&quot; to direct steroidogenesis to this terminal product and prevents DHEA from being converted into biologically active androgens [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/33\" class=\"abstract_t\">33</a>]. </p><p>Enhanced expression of HSD17B5 by this zone seems to account for adrenal testosterone secretion [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/34\" class=\"abstract_t\">34</a>]. 11-hydroxyandrostenedione has emerged as a marker for adrenarche; it is a precursor of 11-ketotestosterone [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/35\" class=\"abstract_t\">35</a>], which is about half as potent as testosterone [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/36\" class=\"abstract_t\">36</a>]. </p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Triggers of adrenarche</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The major factor stimulating the biochemical changes of adrenarche is not known. </p><p>The stimulus has long been thought to be of pituitary origin [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/3,37\" class=\"abstract_t\">3,37</a>]. Several possible stimuli have been proposed: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A <span class=\"nowrap\">Pit-1/POU1F1-dependent</span> factor, possibly prolactin. Adrenarche is severely attenuated in <span class=\"nowrap\">Pit-1/POU1F1</span> deficiency [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/38\" class=\"abstract_t\">38</a>]. This is informative because this pituitary transcription factor is necessary for the secretion of growth hormone, thyrotropin, and prolactin, but not ACTH or other pituitary hormones. Conversely, hyperprolactinemia is accompanied by adrenal androgen excess [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/39\" class=\"abstract_t\">39</a>]. These considerations suggest that prolactin interaction with ACTH is required for adrenarche.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A product of the corticotroph cell, such as a proopiomelanocortin (POMC) product.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A postulated pituitary hormone that is distinct from POMC, termed cortical androgen-stimulating hormone (CASH) by its proponents [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/40\" class=\"abstract_t\">40</a>] and adrenal androgen-stimulating hormone (AASH) by its detractors [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/3\" class=\"abstract_t\">3</a>]. &#160;</p><p/><p>Whatever the factor(s) responsible for adrenarche, it needs to only affect the growth or differentiation of zona reticularis precursor cells so that they acquire the enzymatic properties that permit them to respond to ACTH by secreting androgens. Such a factor might either promote the growth of precursor cells that have a unique biosynthetic capacity, or change the function of cells in the zona reticularis by modifying their pattern of enzyme activity, such as by decreasing the activity of 3&beta;-HSD or enhancing the 17,20-lyase activity of P450c17 [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/15,24,26\" class=\"abstract_t\">15,24,26</a>]. </p><p>Nutritional status, both pre- and postnatal, seems to play a role in the development of adrenarche, particularly in girls. Infants born small for gestational age have higher DHEAS levels at five to eight years of age, and children born large for gestational age have lower levels, than those with normal birth weight [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/41\" class=\"abstract_t\">41</a>]. Adrenal androgen levels are independently associated with low birthweight and with rapid weight gain during early childhood [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/42\" class=\"abstract_t\">42</a>]. Obesity is related to DHEAS levels by seven years of age [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/43\" class=\"abstract_t\">43</a>]. Adrenarche begins at about the same time as the preadolescent increase in adiposity [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/44\" class=\"abstract_t\">44</a>] and leptin levels [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/45\" class=\"abstract_t\">45</a>]. </p><p>It has been postulated that the relationship of adrenarche to body fat in girls is mediated by the compensatory hyperinsulinemia of insulin resistance or the growth <span class=\"nowrap\">hormone/insulin-like</span> growth factor-I axis [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/46\" class=\"abstract_t\">46</a>]. However, insulin-like growth factor-I seems likely to be related to adrenal growth in early childhood rather than to zona reticularis regulation [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/47\" class=\"abstract_t\">47</a>]. It has alternatively been postulated that the increasing body size-to-adrenal size ratio that occurs with somatic growth brings about a rise in the intra-adrenal concentration of cortisol that accentuates adrenarche by inhibiting 3&szlig;-HSD2 [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/26\" class=\"abstract_t\">26</a>].</p><p>Gonadal function affects DHEAS levels. The ovary appears to modulate adrenal DHEAS levels. Ovarian failure and ovariectomy precipitate an earlier rise [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/48\" class=\"abstract_t\">48</a>] and early decline in DHEAS levels, yet estrogen replacement has no beneficial effect on the DHEAS decline [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/49\" class=\"abstract_t\">49</a>]. The testes seem to contribute directly to DHEAS production. Serum DHEAS levels are 50 percent higher in men than women [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/2\" class=\"abstract_t\">2</a>], which is probably explicable by peripheral sulfation of gonadal DHEA since testicular secretion of DHEAS is modest [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/50\" class=\"abstract_t\">50</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">CLINICAL MANIFESTATIONS OF ADRENARCHE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Adrenarchal androgens contribute to the appearance of pubic hair (pubarche) and sebaceous gland and apocrine gland development. Androgens are a prerequisite for the growth and development of the pilosebaceous unit (PSU) in &ldquo;sexual&rdquo; areas of skin [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/51,52\" class=\"abstract_t\">51,52</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Before puberty, the androgen-dependent PSU consists of a prepubertal vellus follicle in which the hair and sebaceous gland components are virtually invisible to the naked eye.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The PSUs of sexual hair areas respond to increasing androgen levels by increasingly switching to production of a thicker type of terminal hair follicle. In acne-prone areas, androgen causes the prepubertal vellus follicle to develop into a sebaceous gland.</p><p/><p>Adrenarchal levels of androgens suffice to successively initiate sebaceous gland development, apocrine gland development, and the growth of pubic hair. Progressively greater amounts of androgen ordinarily stimulate terminal hair development along a pubic to cranial gradient. All these effects of androgen are reversible by antiandrogens. Estrogens also seem to directly promote the growth of sexual hair to a small extent [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/53\" class=\"abstract_t\">53</a>]. </p><p>Adrenarchal androgen action on sebaceous glands is first manifest clinically as microcomedonal acne, which is the basis of the change in facial complexion that occurs in mid-childhood. Adrenarchal androgen action on apocrine glands is manifest as an increase in adult-type body odor. On the basis of correlations between adrenal androgen levels and bone mineral parameters, it has been suggested that adrenal androgens make stronger cortical bone in healthy children [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/54\" class=\"abstract_t\">54</a>]. </p><p>Whether adrenarche plays a more fundamental role in puberty is unknown. It is possible that a threshold level of adrenarchal steroids plays a role in the subtle transient increase in growth rate that is apparent in some growth models at around the age of seven years (&quot;the midgrowth spurt&quot;) or in advancement of the onset of puberty [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/55\" class=\"abstract_t\">55</a>]. Mid-childhood DHEAS levels are associated with earlier age of menarche independently of IGF-I and body mass index (BMI) [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/56\" class=\"abstract_t\">56</a>]. Circulating DHEAS is a precursor for ovarian testosterone formation [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/57\" class=\"abstract_t\">57</a>], while DHEAS formation within the adrenal cortex protects against adrenal hyperandrogenism [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/33\" class=\"abstract_t\">33</a>]. Notably, DHEAS and its precursor, pregnenolone sulfate, are unique among steroids in having direct neurostimulatory effects [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/58,59\" class=\"abstract_t\">58,59</a>]. In the spiny mouse model, DHEA appears to be a neurosteroid, being formed from pregnenolone in the brain [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/8\" class=\"abstract_t\">8</a>]. The association of adrenarchal changes with the emergence of sexually dimorphic sexual attraction, stress-adaptive, and social maturational behavior during middle childhood, prior to true puberty, has led to the suggestion that adrenarchal steroids play a role in activating these behaviors [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/60-62\" class=\"abstract_t\">60-62</a>]. </p><p>DHEA has been suspected of having a number of other unique functions, such as promoting longevity [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/63\" class=\"abstract_t\">63</a>] and quality of life [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/64,65\" class=\"abstract_t\">64,65</a>]. However, data are inconsistent or sparse, and some may be due to DHEA subtly raising testosterone levels [<a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/66,67\" class=\"abstract_t\">66,67</a>].</p><p class=\"headingAnchor\" id=\"H24070796\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Adrenarche describes the maturational increase in adrenal androgen production, which begins at about six years of age in both girls and boys. Adrenarche seems to be unrelated to the pubertal maturation of the hypothalamic-pituitary-gonadal axis, although the clinical manifestations of adrenarche ordinarily closely follow gonadarche. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Adrenarche represents a change in the pattern of adrenal biosynthetic and secretory response to adrenocorticotropic hormone (ACTH), resulting in increases in dehydroepiandrosterone sulfate (DHEAS), which serves as a marker of adrenarche. After adrenarche, DHEAS is more sensitive than cortisol to suppression by glucocorticoid administration. (See <a href=\"#H24070873\" class=\"local\">'Physiology'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The major stimulus of the biochemical changes of adrenarche is not known. It may be of pituitary origin. Whatever the factor may be, it seems to either promote the growth of zona reticularis precursor cells that have a unique biosynthetic capacity or promote the expression of the enzymes that permit the zona reticularis to respond to ACTH by secreting androgens. Nutritional status seems to play a role in the development of adrenarche, which begins at about the same time as the preadolescent increase in adiposity and leptin levels. (See <a href=\"#H3\" class=\"local\">'Triggers of adrenarche'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Adrenarchal androgens contribute to development of sebaceous glands and pubic hair (pubarche), and possibly to bone mineralization. It is less clear whether adrenarche contributes to the subtle transient increase in growth rate that is sometimes observed around the age of seven years (the &quot;midgrowth spurt&quot;) and prepubertal behavior patterns. (See <a href=\"#H4\" class=\"local\">'Clinical manifestations of adrenarche'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/1\" class=\"nounderline abstract_t\">Korth-Schutz S, Levine LS, New MI. Dehydroepiandrosterone sulfate (DS) levels, a rapid test for abnormal adrenal androgen secretion. J Clin Endocrinol Metab 1976; 42:1005.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/2\" class=\"nounderline abstract_t\">de Peretti E, Forest MG. Pattern of plasma dehydroepiandrosterone sulfate levels in humans from birth to adulthood: evidence for testicular production. J Clin Endocrinol Metab 1978; 47:572.</a></li><li class=\"breakAll\">Grumbach M, Richards C, Conte F, Kaplan S. Clinical disorders of adrenal function and puberty: An assessment of the role of the adrenal cortex in normal and abnormal puberty in man and evidence for an ACTH-like pituitary adrenal androgen stimu. In: The endocrine function of the human adrenal cortex, James V, Serio M, Giusti C, Martini L (Eds), Academic Press, London 1978. p.583.</li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/4\" class=\"nounderline abstract_t\">Ib&aacute;&ntilde;ez L, Dimartino-Nardi J, Potau N, Saenger P. Premature adrenarche--normal variant or forerunner of adult disease? Endocr Rev 2000; 21:671.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/5\" class=\"nounderline abstract_t\">Nakamura Y, Gang HX, Suzuki T, et al. Adrenal changes associated with adrenarche. Rev Endocr Metab Disord 2009; 10:19.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/6\" class=\"nounderline abstract_t\">Nguyen AD, Mapes SM, Corbin CJ, Conley AJ. Morphological adrenarche in rhesus macaques: development of the zona reticularis is concurrent with fetal zone regression in the early neonatal period. J Endocrinol 2008; 199:367.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/7\" class=\"nounderline abstract_t\">Conley AJ, Plant TM, Abbott DH, et al. Adrenal androgen concentrations increase during infancy in male rhesus macaques (Macaca mulatta). Am J Physiol Endocrinol Metab 2011; 301:E1229.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/8\" class=\"nounderline abstract_t\">Quinn TA, Ratnayake U, Dickinson H, et al. The feto-placental unit, and potential roles of dehydroepiandrosterone (DHEA) in prenatal and postnatal brain development: A re-examination using the spiny mouse. J Steroid Biochem Mol Biol 2016; 160:204.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/9\" class=\"nounderline abstract_t\">Rich BH, Rosenfield RL, Lucky AW, et al. Adrenarche: changing adrenal response to adrenocorticotropin. J Clin Endocrinol Metab 1981; 52:1129.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/10\" class=\"nounderline abstract_t\">Weber A, Clark AJ, Perry LA, et al. Diminished adrenal androgen secretion in familial glucocorticoid deficiency implicates a significant role for ACTH in the induction of adrenarche. Clin Endocrinol (Oxf) 1997; 46:431.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/11\" class=\"nounderline abstract_t\">Rosenfield RL. Plasma 17-ketosteroids and 17-beta hydroxysteroids in girls with premature development of sexual hair. J Pediatr 1971; 79:260.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/12\" class=\"nounderline abstract_t\">Rittmaster RS, Givner ML. Effect of daily and alternate day low dose prednisone on serum cortisol and adrenal androgens in hirsute women. J Clin Endocrinol Metab 1988; 67:400.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/13\" class=\"nounderline abstract_t\">Brigell DF, Fang VS, Rosenfield RL. Recovery of responses to ovine corticotropin-releasing hormone after withdrawal of a short course of glucocorticoid. J Clin Endocrinol Metab 1992; 74:1036.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/14\" class=\"nounderline abstract_t\">Endoh A, Kristiansen SB, Casson PR, et al. The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3 beta-hydroxysteroid dehydrogenase. J Clin Endocrinol Metab 1996; 81:3558.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/15\" class=\"nounderline abstract_t\">Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 2011; 32:81.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/16\" class=\"nounderline abstract_t\">Udhane SS, Fl&uuml;ck CE. Regulation of human (adrenal) androgen biosynthesis-New insights from novel throughput technology studies. Biochem Pharmacol 2016; 102:20.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/17\" class=\"nounderline abstract_t\">Biason-Lauber A, Zachmann M, Schoenle EJ. Effect of leptin on CYP17 enzymatic activities in human adrenal cells: new insight in the onset of adrenarche. Endocrinology 2000; 141:1446.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/18\" class=\"nounderline abstract_t\">Ehrhart-Bornstein M, Hinson JP, Bornstein SR, et al. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev 1998; 19:101.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/19\" class=\"nounderline abstract_t\">P&auml;th G, Bornstein SR, Ehrhart-Bornstein M, Scherbaum WA. Interleukin-6 and the interleukin-6 receptor in the human adrenal gland: expression and effects on steroidogenesis. J Clin Endocrinol Metab 1997; 82:2343.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/20\" class=\"nounderline abstract_t\">Lerario AM, Finco I, LaPensee C, Hammer GD. Molecular Mechanisms of Stem/Progenitor Cell Maintenance in the Adrenal Cortex. Front Endocrinol (Lausanne) 2017; 8:52.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/21\" class=\"nounderline abstract_t\">Penny MK, Finco I, Hammer GD. Cell signaling pathways in the adrenal cortex: Links to stem/progenitor biology and neoplasia. Mol Cell Endocrinol 2017; 445:42.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/22\" class=\"nounderline abstract_t\">Hui XG, Akahira J, Suzuki T, et al. Development of the human adrenal zona reticularis: morphometric and immunohistochemical studies from birth to adolescence. J Endocrinol 2009; 203:241.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/23\" class=\"nounderline abstract_t\">Blackman, SJ. Concerning the function and origin of the reticular zone of the adrenal cortex. Bull Hopkins Hosp 1946; 78:180.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/24\" class=\"nounderline abstract_t\">Rainey WE, Carr BR, Sasano H, et al. Dissecting human adrenal androgen production. Trends Endocrinol Metab 2002; 13:234.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/25\" class=\"nounderline abstract_t\">Dickerman Z, Grant DR, Faiman C, Winter JS. Intraadrenal steroid concentrations in man: zonal differences and developmental changes. J Clin Endocrinol Metab 1984; 59:1031.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/26\" class=\"nounderline abstract_t\">Topor LS, Asai M, Dunn J, Majzoub JA. Cortisol stimulates secretion of dehydroepiandrosterone in human adrenocortical cells through inhibition of 3betaHSD2. J Clin Endocrinol Metab 2011; 96:E31.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/27\" class=\"nounderline abstract_t\">Byrne GC, Perry YS, Winter JS. Kinetic analysis of adrenal 3 beta-hydroxysteroid dehydrogenase activity during human development. J Clin Endocrinol Metab 1985; 60:934.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/28\" class=\"nounderline abstract_t\">Thomas JL, Rajapaksha M, Mack VL, et al. Regulation of human 3&beta;-hydroxysteroid dehydrogenase type 2 by adrenal corticosteroids and product-feedback by androstenedione in human adrenarche. J Pharmacol Exp Ther 2015; 352:67.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/29\" class=\"nounderline abstract_t\">Winter JS, Smail PJ. Effects of ACTH and estradiol on steroid production by cultured adrenal cells from an anencephalic fetus and from normal adults. Steroids 1983; 42:677.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/30\" class=\"nounderline abstract_t\">Bellanger S, Battista MC, Fink GD, Baillargeon JP. Saturated fatty acid exposure induces androgen overproduction in bovine adrenal cells. Steroids 2012; 77:347.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/31\" class=\"nounderline abstract_t\">Schiebinger RJ, Albertson BD, Cassorla FG, et al. The developmental changes in plasma adrenal androgens during infancy and adrenarche are associated with changing activities of adrenal microsomal 17-hydroxylase and 17,20-desmolase. J Clin Invest 1981; 67:1177.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/32\" class=\"nounderline abstract_t\">Rege J, Karashima S, Lerario AM, et al. Age-dependent Increases in Adrenal Cytochrome b5 and Serum 5-Androstenediol-3-sulfate. J Clin Endocrinol Metab 2016; 101:4585.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/33\" class=\"nounderline abstract_t\">Noordam C, Dhir V, McNelis JC, et al. Inactivating PAPSS2 mutations in a patient with premature pubarche. N Engl J Med 2009; 360:2310.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/34\" class=\"nounderline abstract_t\">Nakamura Y, Hornsby PJ, Casson P, et al. Type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis. J Clin Endocrinol Metab 2009; 94:2192.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/35\" class=\"nounderline abstract_t\">Turcu AF, Auchus RJ. Clinical significance of 11-oxygenated androgens. Curr Opin Endocrinol Diabetes Obes 2017; 24:252.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/36\" class=\"nounderline abstract_t\">Rege J, Nakamura Y, Satoh F, et al. Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation. J Clin Endocrinol Metab 2013; 98:1182.</a></li><li class=\"breakAll\">Mills I, Brooks R, Prunty F. The relationship between the production of cortisol and androgen by the human adrenal. In: The human adrenal cortex, Currie A, Symington T, Grant J (Eds), Williams &amp; Wilkins, Baltimore 1962.</li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/38\" class=\"nounderline abstract_t\">Taha D, Mullis PE, Ib&aacute;&ntilde;ez L, de Zegher F. Absent or delayed adrenarche in Pit-1/POU1F1 deficiency. Horm Res 2005; 64:175.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/39\" class=\"nounderline abstract_t\">Glickman SP, Rosenfield RL, Bergenstal RM, Helke J. Multiple androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic women. J Clin Endocrinol Metab 1982; 55:251.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/40\" class=\"nounderline abstract_t\">Parker LN. Adrenarche. Endocrinol Metab Clin North Am 1991; 20:71.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/41\" class=\"nounderline abstract_t\">Nordman H, Voutilainen R, Antikainen L, J&auml;&auml;skel&auml;inen J. Prepubertal children born large for gestational age have lower serum DHEAS concentrations than those with a lower birth weight. Pediatr Res 2017; 82:285.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/42\" class=\"nounderline abstract_t\">Ong KK, Potau N, Petry CJ, et al. Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls. J Clin Endocrinol Metab 2004; 89:2647.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/43\" class=\"nounderline abstract_t\">Corval&aacute;n C, Uauy R, Mericq V. Obesity is positively associated with dehydroepiandrosterone sulfate concentrations at 7 y in Chilean children of normal birth weight. Am J Clin Nutr 2013; 97:318.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/44\" class=\"nounderline abstract_t\">Smith CP, Dunger DB, Williams AJ, et al. Relationship between insulin, insulin-like growth factor I, and dehydroepiandrosterone sulfate concentrations during childhood, puberty, and adult life. J Clin Endocrinol Metab 1989; 68:932.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/45\" class=\"nounderline abstract_t\">B&#322;ogowska A, Rzepka-G&oacute;rska I, Krzyzanowska-Swiniarska B. Body composition, dehydroepiandrosterone sulfate and leptin concentrations in girls approaching menarche. J Pediatr Endocrinol Metab 2005; 18:975.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/46\" class=\"nounderline abstract_t\">Guercio G, Rivarola MA, Chaler E, et al. Relationship between the growth hormone/insulin-like growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls. J Clin Endocrinol Metab 2003; 88:1389.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/47\" class=\"nounderline abstract_t\">Baquedano MS, Berensztein E, Saraco N, et al. Expression of the IGF system in human adrenal tissues from early infancy to late puberty: implications for the development of adrenarche. Pediatr Res 2005; 58:451.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/48\" class=\"nounderline abstract_t\">Martin DD, Schweizer R, Schwarze CP, et al. The early dehydroepiandrosterone sulfate rise of adrenarche and the delay of pubarche indicate primary ovarian failure in Turner syndrome. J Clin Endocrinol Metab 2004; 89:1164.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/49\" class=\"nounderline abstract_t\">Cumming DC, Rebar RW, Hopper BR, Yen SS. Evidence for an influence of the ovary on circulating dehydroepiandrosterone sulfate levels. J Clin Endocrinol Metab 1982; 54:1069.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/50\" class=\"nounderline abstract_t\">Laatikainen T, Laitinen EA, Vihko R. Secretion of free and sulfate-conjugated neutral steroids by the human testis. Effect of administration of human chorionic gonadotropin. J Clin Endocrinol Metab 1971; 32:59.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/51\" class=\"nounderline abstract_t\">Rosenfield RL. Clinical practice. Hirsutism. N Engl J Med 2005; 353:2578.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/52\" class=\"nounderline abstract_t\">Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev 2000; 21:363.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/53\" class=\"nounderline abstract_t\">Rosenfield RL, Fang VS. The effects of prolonged physiologic estradiol therapy on the maturation of hypogonadal teen-agers. J Pediatr 1974; 85:830.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/54\" class=\"nounderline abstract_t\">Remer T, Boye KR, Hartmann M, et al. Adrenarche and bone modeling and remodeling at the proximal radius: weak androgens make stronger cortical bone in healthy children. J Bone Miner Res 2003; 18:1539.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/55\" class=\"nounderline abstract_t\">Remer T, Shi L, Buyken AE, et al. Prepubertal adrenarchal androgens and animal protein intake independently and differentially influence pubertal timing. J Clin Endocrinol Metab 2010; 95:3002.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/56\" class=\"nounderline abstract_t\">Thankamony A, Ong KK, Ahmed ML, et al. Higher levels of IGF-I and adrenal androgens at age 8 years are associated with earlier age at menarche in girls. J Clin Endocrinol Metab 2012; 97:E786.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/57\" class=\"nounderline abstract_t\">Haning RV Jr, Hackett RJ, Flood CA, et al. Plasma dehydroepiandrosterone sulfate serves as a prehormone for 48% of follicular fluid testosterone during treatment with menotropins. J Clin Endocrinol Metab 1993; 76:1301.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/58\" class=\"nounderline abstract_t\">Paul SM, Purdy RH. Neuroactive steroids. FASEB J 1992; 6:2311.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/59\" class=\"nounderline abstract_t\">Asaba H, Hosoya K, Takanaga H, et al. Blood-brain barrier is involved in the efflux transport of a neuroactive steroid, dehydroepiandrosterone sulfate, via organic anion transporting polypeptide 2. J Neurochem 2000; 75:1907.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/60\" class=\"nounderline abstract_t\">Campbell BC. Adrenarche and middle childhood. Hum Nat 2011; 22:327.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/61\" class=\"nounderline abstract_t\">Del Giudice M. Sex, attachment, and the development of reproductive strategies. Behav Brain Sci 2009; 32:1.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/62\" class=\"nounderline abstract_t\">Herdt G, McClintock M. The magical age of 10. Arch Sex Behav 2000; 29:587.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/63\" class=\"nounderline abstract_t\">Yerges-Armstrong LM, Chai S, O'Connell JR, et al. Gene Expression Differences Between Offspring of Long-Lived Individuals and Controls in Candidate Longevity Regions: Evidence for PAPSS2 as a Longevity Gene. J Gerontol A Biol Sci Med Sci 2016; 71:1295.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/64\" class=\"nounderline abstract_t\">Brooke AM, Kalingag LA, Miraki-Moud F, et al. Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement. J Clin Endocrinol Metab 2006; 91:3773.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/65\" class=\"nounderline abstract_t\">Mortola JF, Yen SS. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab 1990; 71:696.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/66\" class=\"nounderline abstract_t\">Nair KS, Rizza RA, O'Brien P, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 2006; 355:1647.</a></li><li><a href=\"https://www.uptodate.com/contents/normal-adrenarche/abstract/67\" class=\"nounderline abstract_t\">Davis SR, Panjari M, Stanczyk FZ. Clinical review: DHEA replacement for postmenopausal women. J Clin Endocrinol Metab 2011; 96:1642.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 5798 Version 15.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H24070796\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H24070873\" id=\"outline-link-H24070873\">PHYSIOLOGY</a><ul><li><a href=\"#H2\" id=\"outline-link-H2\">Anatomic site and mechanism of biochemical changes</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">Triggers of adrenarche</a></li></ul></li><li><a href=\"#H4\" id=\"outline-link-H4\">CLINICAL MANIFESTATIONS OF ADRENARCHE</a></li><li><a href=\"#H24070796\" id=\"outline-link-H24070796\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PEDS/5798|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/79533\" class=\"graphic graphic_figure\">- DHEAS pubic hair develop</a></li><li><a href=\"image.htm?imageKey=PEDS/53342\" class=\"graphic graphic_figure\">- Hormonal changes during adrenarche</a></li><li><a href=\"image.htm?imageKey=PEDS/58179\" class=\"graphic graphic_figure\">- Steroidogenesis by zone</a></li></ul></li><li><div id=\"PEDS/5798|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/75217\" class=\"graphic graphic_table\">- Androgen range child</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=adrenal-steroid-biosynthesis\" class=\"medical medical_review\">Adrenal steroid biosynthesis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=premature-adrenarche\" class=\"medical medical_review\">Premature adrenarche</a></li></ul></div></div>","javascript":null}